CYP2C19-IN-1
CYP2C19-IN-1 (compound 20d) is a potent CYP2C19 inhibitor, possessing no hepatotoxicity and ames toxicity. CYP2C19-IN-1 inhibits RNA-dependent RNA polymerase (RdRP) with a Ki value of 6.16 µM. CYP2C19-IN-1 can be used in study of anti-ZIKV[1].
Product Specifications
CAS Number
3010895-53-8
UNSPSC
12352005
Target
Cytochrome P450; DNA/RNA Synthesis; Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cyp2c19-in-1.html
Solubility
10 mM in DMSO
Smiles
O=S(CC1=CC=C2C=C(C3=CC(N(C(N4)=O)C=CC4=O)=CC(C(C)(C)C)=C3OC)C=CC2=C1)(O)=O
Molecular Formula
C26H26N2O6S
Molecular Weight
494.56
References & Citations
[1]Ezeh M I, et al. Chemoinformatic Design and Profiling of Derivatives of Dasabuvir, Efavirenz, and Tipranavir as Potential Inhibitors of Zika Virus RNA-Dependent RNA Polymerase and Methyltransferase. ACS Omega, 2022 Sep 5.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
T01782-96-T 96 Tests
RT PCR test for S.aureus resistance, genes MecA (12 x 8 strip format)
Sign In for Pricing
View Details 
MBS6357007-01 0.1 mL
TNFRSF6B, NT (TNFRSF6B, DCR3, TR6, Tumor necrosis factor receptor superfamily member 6B, Decoy receptor 3, Decoy receptor for Fas ligand, M68) (MaxLight 650)
Sign In for Pricing
View Details MBS6357007-02 5x 0.1 mL
TNFRSF6B, NT (TNFRSF6B, DCR3, TR6, Tumor necrosis factor receptor superfamily member 6B, Decoy receptor 3, Decoy receptor for Fas ligand, M68) (MaxLight 650)
Sign In for Pricing
View Details 307762-01 50 µL
BCL2/adenovirus E1B 19kD Protein-interacting Protein 3 (BNIP3)
Sign In for Pricing
View Details 307762-02 100 µL
BCL2/adenovirus E1B 19kD Protein-interacting Protein 3 (BNIP3)
Sign In for Pricing
View Details